Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
145.80
+0.90 (0.62%)
At close: Oct 15, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 65.04 billion as of October 15, 2026. It is the 14,319th most valuable company in the world and the 10th biggest in Bangladesh. Its market cap has increased by 28.80% in one year.
Market Cap
65.04B
Enterprise Value
66.47B
Revenue
53.93B
Global Rank
Country Rank
#10 Bangladesh
PE Ratio
7.52
ChartMarket Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 65.04B, an increase of 3,303.77%. That is a compound annual growth rate of 14.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 65.04B | 42.80% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 194.66B |
| Renata | 51.25B |
| Unilever Consumer Care | 38.12B |
| Beacon Pharmaceuticals | 23.26B |
| The ACME Laboratories | 16.29B |
| Asiatic Laboratories | 12.64B |
| The IBN SINA Pharmaceutical Industry | 9.63B |
| Navana Pharmaceuticals | 6.72B |